The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation ( MANTRA-PAF ) trial assessed the long-term efficacy of an initial strategy of radiofrequency ablation ( RFA ) vs. antiarrhythmic drug therapy ( AAD ) as first-line treatment for patients with PAF .